Community Health Media
Cancer Unfiltered
Candid podcast where leading oncologists and experts speak openly about the realities of cancer care. Through honest conversations, real-world insights, and expert perspectives, the show tackles the complex topics shaping oncology today—without the filters.
Be sure to visit the podcast's website and support the creator: podcasters.spotify.com
Author
Community Health Media
Category
Podcast website
Latest episode
Oct 29, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Cancer Unfiltered Ep. 5: ctDNA Switch, Stop or Add with Dr. Heather Parsons & Julia Maués 29.10.2026 51:35
Can a simple blood test tell us when to switch, stop, or add breast cancer treatment? In Episode 5 of Cancer Unfiltered, Dr. Komal Jhaveri and Dr. Neil Iyengar are joined by Dr. Heather Parsons and patient advocate Julia Maués to explore the evolving role of circulating tumor DNA (ctDNA) in breast cancer treatment decisions. From SERENA-6 and switching therapy before radiographic progression to HE...
Cancer Unfiltered Ep. 4: VIKTORIA-1 in HR+ mBC with Drs. Komal Jhaveri & Neil Iyengar 24.08.2026 28:45
One trial. One therapy. Countless clinical questions. In Episode 4 of Cancer Unfiltered, Dr. Komal Jhaveri and Dr. Neil Iyengar take a deep dive into the VIKTORIA-1 trial and discuss how gedatolisib may reshape treatment for patients with HR-positive, HER2-negative metastatic breast cancer. Beyond reviewing the data, they explore where this regimen fits in clinical practice, who may benefit most,...
Cancer Unfiltered Ep. 3: New FDA Approvals, Practice-Changing Trials & What's Next in Breast Cancer 30.07.2026 35:10
Breast cancer treatment is changing at an unprecedented pace. In Episode 3 of Cancer Unfiltered, Dr. Komal Jhaveri and Dr. Neil Iyengar discuss the latest FDA approvals, landmark clinical trials, and emerging treatment strategies that are reshaping care across HR-positive, HER2-positive, and triple-negative breast cancer. From practice-changing DESTINY data to the expanding role of antibody-drug c...
Cancer Unfiltered Ep. 2: ESMO Breast 2026 with Drs. Komal Jhaveri & Neil Iyengar 30.06.2026 44:20
The conversation continues. In Episode 2 of Cancer Unfiltered, Dr. Komal Jhaveri and Dr. Neil Iyengar break down the biggest updates from ESMO Breast 2026, including DESTINY-Breast11, SERENA-6, ctDNA monitoring, exercise and metabolic health, emerging novel therapies, and the future of ER-positive breast cancer treatment. From controversial questions surrounding molecular progression to exciting n...
Cancer Unfiltered Bonus: How Drs. Jhaveri & Iyengar See the Future of Breast Cancer 30.06.2026 32:12
Before the data drops, the hot takes, and the controversies, there was Miami. In this special bonus episode, Dr. Komal Jhaveri and Dr. Neil Iyengar introduce Cancer Unfiltered and discuss the biggest questions shaping breast oncology today. From oral SERDs and overcoming ESR1 mutations to the monotherapy vs. combination debate, ADC sequencing, first-line triple-negative breast cancer strategies, a...
Cancer Unfiltered Ep. 1: Shifting Paradigms in Breast Cancer with Drs. Komal Jhaveri & Neil Iyengar 26.05.2026 36:37
What happens when two leading breast oncologists sit down for an unfiltered conversation on the biggest breakthroughs, controversies, and real-world challenges in breast cancer today? In Episode 1 of Cancer Unfiltered, Dr. Komal Jhaveri and Dr. Neil Iyengar break down the latest data in metastatic breast cancer, including SERENA-6, PATINA, HER2CLIMB-05, DB-09, oral SERDs, ctDNA monitoring, and the...
Cancer Unfiltered Debut: Dr. Komal Jhaveri & Dr. Neil Iyengar on Breast Cancer 26.05.2026 0:55
The conversations oncology has been waiting for are finally here. Welcome to the very first episode of Cancer Unfiltered with Dr. Komal Jhaveri & Dr. Neil Iyengar. From SERDs and ctDNA to resistance mechanisms, NGS profiling, T-DXd, and the future of metastatic breast cancer treatment, nothing is off limits. Real conversations. Real controversies. Real clinical insight. This is oncology withou...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.